No repeat blood draws.
High pressures during blood collection rupture red blood cells, compromising the sample.
Frontline clinicians and lab teams are left dealing with the consequences of inadequately designed tools.
Labs reject the sample. Clinicians redraw. Patients wait.
The first blood-draw syringe built to reduce hemolysis during collection for every patient
Designed to modulate pressure during aspiration, reducing mechanical stress on red blood cells.
Our approach focuses on improving modulating pressure during collection, reducing mechanical stress on red blood cells. We've designed and iterated with nurses, ensuring our device doesn't add steps, complexity, or workflow burden.
By addressing sample quality upstream, we aim to reduce downstream consequences for labs, clinicians, and patients.
Average cost impact per Hemolyzed sample:
$300
For a hospital with 600K annual blood draws:
$18M loss